
|Articles|October 1, 2012
SCC prevention is real target in treating actinic keratoses
Options for topical treatment of actinic keratoses (AKs) are increasing, but in choosing a management approach, dermatologists should keep in mind that AKs are a premalignant condition, and the ultimate goal of therapy is prevention of squamous cell carcinoma (SCC). Field treatment is the key to managing the entire disease, says Neal Bhatia, M.D.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
KT-621 in Atopic Dermatitis: What Early EASI and Pruritus Data Show
2
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
3
Social Media Mythbusters: Skin Cycling
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














